|
Academic Year: | 2016/7 |
Owning Department/School: | Department of Pharmacy & Pharmacology |
Credits: | 6 [equivalent to 12 CATS credits] |
Notional Study Hours: | 120 |
Level: | Masters UG & PG (FHEQ level 7) |
Period: |
|
Assessment Summary: | CW 100% |
Assessment Detail: |
|
Supplementary Assessment: |
|
Requisites: | |
Description: | Aims: To update pharmacists on the disease and patient monitoring factors that should be considered when providing pharmaceutical care for patients with conditions of the endocrine system. Learning Outcomes: On successful completion of this unit the student will be able to: 1. Describe and analyse the role of the healthcare professional / pharmacist in prescribing, administration and monitoring of medication for patients with diseases of the endocrine system (knowledge and understanding). 2. Explain the disease and patient monitoring factors in this therapeutic area (knowledge and understanding, professional practical skill). 3. Critically evaluate the evidence base for the management of endocrine disease (intellectual skill). 4. Reflect on their own practice in supporting patients with this disease and identify areas for continuous improvement (personal transferable skill). 5. Apply the knowledge gained in this unit to design enhancements to patient facing services and the patient experience (professional practical skill; intellectual skill; knowledge and understanding). Skills: * Planning & organisation (Taught/Facilitated) * Study skills (Taught/Facilitated) * Handling information (Taught/Facilitated) * Written communication (Taught/Facilitated/Assessed) * Working with others (Taught/Facilitated) * Scientific & practical skills (Taught/Facilitated/Assessed) * Improving learning & performance (Taught/Facilitated) * Information & communication technology (ICT) (Taught/Facilitated) * Problem solving (Taught/Facilitated). Content: * Unit Introduction * Hormonal Contraception and Fertility * Hormone Replacement Therapy * Diabetes - Type 1 * Diabetes - Type 2 * Diabetes - Complications * Thyroid Conditions * Pituitary Disorders * Osteoporosis. |
Programme availability: |
PA50201 is Optional on the following programmes:Department of Pharmacy & Pharmacology
|
Notes:
|